Lecanemab for Alzheimer’s disease: Discussing risks and benefits is key

Credit: Pixabay/CC0 Public Domain

Canada recently approved lecanemab to treat early Alzheimer’s disease, but the clinical benefits are modest, it…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *